 | • レポートコード：B-GIR08C5678 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、NSCLC用標的薬の世界市場について調べ、まとめました。種類別セグメントは、ターゲットEGFR、ターゲットALK、ターゲットHER2、ターゲットROS1、ターゲットBRAF、ターゲットMEK、ターゲットVEGFR2、ターゲットVEGF、ターゲットMET等、用途別セグメントは、等に区分しました。NSCLC用標的薬の世界市場概観、企業動向、企業別NSCLC用標的薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・NSCLC用標的薬の市場概観 ・NSCLC用標的薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・NSCLC用標的薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・NSCLC用標的薬の世界市場規模 ・NSCLC用標的薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・NSCLC用標的薬のアメリカ市場規模推移 ・NSCLC用標的薬のカナダ市場規模推移 ・NSCLC用標的薬のメキシコ市場規模推移 ・NSCLC用標的薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・NSCLC用標的薬のドイツ市場規模推移 ・NSCLC用標的薬のイギリス市場規模推移 ・NSCLC用標的薬のロシア市場規模推移 ・NSCLC用標的薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・NSCLC用標的薬の日本市場規模推移 ・NSCLC用標的薬の中国市場規模推移 ・NSCLC用標的薬の韓国市場規模推移 ・NSCLC用標的薬のインド市場規模推移 ・NSCLC用標的薬の東南アジア市場規模推移 ・NSCLC用標的薬の南米市場分析（ブラジル、アルゼンチン等） ・NSCLC用標的薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・NSCLC用標的薬の種類別分析/販売量、売上、市場シェア（ターゲットEGFR、ターゲットALK、ターゲットHER2、ターゲットROS1、ターゲットBRAF、ターゲットMEK、ターゲットVEGFR2、ターゲットVEGF、ターゲットMET） ・NSCLC用標的薬の用途別分析/市場規模（） ・NSCLC用標的薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・NSCLC用標的薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Targeted Drugs for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Targeted Drugs for NSCLC.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Targeted Drugs for NSCLC market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Targeted Drugs for NSCLC market by product type and applications/end industries.
Market Segment by Companies, this report covers
Allergan
Amgen
ARIAD Pharmaceuticals (Takeda)
Beacon Pharma Limited
BeiGene
Biocon
Boehringer-Ingelheim
Celgene Corporation
Drug International Limted
Fujifilm Kyowa Kirin Biologics
Genvio Pharma Limited
Hetero Drugs
ImClone Systems (Eli Lilly)
Incepta Pharmaceuticals
Mylan
Novartis
Pfizer
Reliance Lifesciences
Roche
AstraZeneca
Cipla
Teva
OSI Pharmaceuticals
Glenmark Pharmaceuticals
Natco Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Target EGFR
Target ALK
Target HER2
Target ROS1
Target BRAF
Target MEK
Target VEGFR2
Target VEGF
Target MET
Market Segment by Applications, can be divided into
Squamous Cell Carcinoma of NSCLC
Adenocarcinoma of NSCLC
Large Cell Carcinoma of NSCLC
Table of Contents
1 Targeted Drugs for NSCLC Market Overview
1.1 Product Overview and Scope of Targeted Drugs for NSCLC
1.2 Classification of Targeted Drugs for NSCLC by Types
1.2.1 Global Targeted Drugs for NSCLC Revenue Comparison by Types (2019-2024)
1.2.2 Global Targeted Drugs for NSCLC Revenue Market Share by Types in 2018
1.2.3 Target EGFR
1.2.4 Target ALK
1.2.5 Target HER2
1.2.6 Target ROS1
1.2.7 Target BRAF
1.2.8 Target MEK
1.2.9 Target VEGFR2
1.2.10 Target VEGF
1.2.11 Target MET
1.3 Global Targeted Drugs for NSCLC Market by Application
1.3.1 Global Targeted Drugs for NSCLC Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Squamous Cell Carcinoma of NSCLC
1.3.3 Adenocarcinoma of NSCLC
1.3.4 Large Cell Carcinoma of NSCLC
1.4 Global Targeted Drugs for NSCLC Market by Regions
1.4.1 Global Targeted Drugs for NSCLC Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Targeted Drugs for NSCLC Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Targeted Drugs for NSCLC Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Targeted Drugs for NSCLC Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Targeted Drugs for NSCLC Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Targeted Drugs for NSCLC Status and Prospect (2014-2024)
1.5 Global Market Size of Targeted Drugs for NSCLC (2014-2024)
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Targeted Drugs for NSCLC Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Targeted Drugs for NSCLC Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.3 ARIAD Pharmaceuticals (Takeda)
2.3.1 Business Overview
2.3.2 Targeted Drugs for NSCLC Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.4 Beacon Pharma Limited
2.4.1 Business Overview
2.4.2 Targeted Drugs for NSCLC Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Beacon Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.5 BeiGene
2.5.1 Business Overview
2.5.2 Targeted Drugs for NSCLC Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BeiGene Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.6 Biocon
2.6.1 Business Overview
2.6.2 Targeted Drugs for NSCLC Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biocon Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.7 Boehringer-Ingelheim
2.7.1 Business Overview
2.7.2 Targeted Drugs for NSCLC Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.8 Celgene Corporation
2.8.1 Business Overview
2.8.2 Targeted Drugs for NSCLC Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corporation Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.9 Drug International Limted
2.9.1 Business Overview
2.9.2 Targeted Drugs for NSCLC Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Drug International Limted Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.10 Fujifilm Kyowa Kirin Biologics
2.10.1 Business Overview
2.10.2 Targeted Drugs for NSCLC Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.11 Genvio Pharma Limited
2.11.1 Business Overview
2.11.2 Targeted Drugs for NSCLC Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Genvio Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.12 Hetero Drugs
2.12.1 Business Overview
2.12.2 Targeted Drugs for NSCLC Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Hetero Drugs Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.13 ImClone Systems (Eli Lilly)
2.13.1 Business Overview
2.13.2 Targeted Drugs for NSCLC Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 ImClone Systems (Eli Lilly) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.14 Incepta Pharmaceuticals
2.14.1 Business Overview
2.14.2 Targeted Drugs for NSCLC Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.15 Mylan
2.15.1 Business Overview
2.15.2 Targeted Drugs for NSCLC Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Mylan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.16 Novartis
2.16.1 Business Overview
2.16.2 Targeted Drugs for NSCLC Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Novartis Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.17 Pfizer
2.17.1 Business Overview
2.17.2 Targeted Drugs for NSCLC Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pfizer Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.18 Reliance Lifesciences
2.18.1 Business Overview
2.18.2 Targeted Drugs for NSCLC Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Reliance Lifesciences Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.19 Roche
2.19.1 Business Overview
2.19.2 Targeted Drugs for NSCLC Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Roche Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.20 AstraZeneca
2.20.1 Business Overview
2.20.2 Targeted Drugs for NSCLC Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 AstraZeneca Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.21 Cipla
2.21.1 Business Overview
2.2.2 Targeted Drugs for NSCLC Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Cipla Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.22 Teva
2.22.1 Business Overview
2.22.2 Targeted Drugs for NSCLC Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Teva Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.23 OSI Pharmaceuticals
2.23.1 Business Overview
2.23.2 Targeted Drugs for NSCLC Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.24 Glenmark Pharmaceuticals
2.24.1 Business Overview
2.24.2 Targeted Drugs for NSCLC Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.25 Natco Pharma
2.25.1 Business Overview
2.25.2 Targeted Drugs for NSCLC Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Natco Pharma Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
3 Global Targeted Drugs for NSCLC Market Competition, by Players
3.1 Global Targeted Drugs for NSCLC Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Targeted Drugs for NSCLC Players Market Share
3.2.2 Top 10 Targeted Drugs for NSCLC Players Market Share
3.3 Market Competition Trend
4 Global Targeted Drugs for NSCLC Market Size by Regions
4.1 Global Targeted Drugs for NSCLC Revenue and Market Share by Regions
4.2 North America Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
4.3 Europe Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
4.5 South America Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
5 North America Targeted Drugs for NSCLC Revenue by Countries
5.1 North America Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
5.2 USA Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
5.3 Canada Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
5.4 Mexico Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
6 Europe Targeted Drugs for NSCLC Revenue by Countries
6.1 Europe Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
6.2 Germany Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
6.3 UK Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
6.4 France Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
6.5 Russia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
6.6 Italy Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Targeted Drugs for NSCLC Revenue by Countries
7.1 Asia-Pacific Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
7.2 China Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
7.3 Japan Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
7.4 Korea Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
7.5 India Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
8 South America Targeted Drugs for NSCLC Revenue by Countries
8.1 South America Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
8.2 Brazil Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
8.3 Argentina Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
8.4 Colombia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Targeted Drugs for NSCLC by Countries
9.1 Middle East and Africa Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
9.2 Saudi Arabia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
9.3 UAE Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
9.4 Egypt Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
9.5 Nigeria Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
9.6 South Africa Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
10 Global Targeted Drugs for NSCLC Market Segment by Type
10.1 Global Targeted Drugs for NSCLC Revenue and Market Share by Type (2014-2019)
10.2 Global Targeted Drugs for NSCLC Market Forecast by Type (2019-2024)
10.3 Target EGFR Revenue Growth Rate (2014-2024)
10.4 Target ALK Revenue Growth Rate (2014-2024)
10.5 Target HER2 Revenue Growth Rate (2014-2024)
10.6 Target ROS1 Revenue Growth Rate (2014-2024)
10.7 Target BRAF Revenue Growth Rate (2014-2024)
10.8 Target MEK Revenue Growth Rate (2014-2024)
10.9 Target VEGFR2 Revenue Growth Rate (2014-2024)
10.10 Target VEGF Revenue Growth Rate (2014-2024)
10.11 Target MET Revenue Growth Rate (2014-2024)
11 Global Targeted Drugs for NSCLC Market Segment by Application
11.1 Global Targeted Drugs for NSCLC Revenue Market Share by Application (2014-2019)
11.2 Targeted Drugs for NSCLC Market Forecast by Application (2019-2024)
11.3 Squamous Cell Carcinoma of NSCLC Revenue Growth (2014-2019)
11.4 Adenocarcinoma of NSCLC Revenue Growth (2014-2019)
11.5 Large Cell Carcinoma of NSCLC Revenue Growth (2014-2019)
12 Global Targeted Drugs for NSCLC Market Size Forecast (2019-2024)
12.1 Global Targeted Drugs for NSCLC Market Size Forecast (2019-2024)
12.2 Global Targeted Drugs for NSCLC Market Forecast by Regions (2019-2024)
12.3 North America Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
12.4 Europe Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
12.6 South America Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Targeted Drugs for NSCLC Picture
Table Product Specifications of Targeted Drugs for NSCLC
Table Global Targeted Drugs for NSCLC and Revenue (Million USD) Market Split by Product Type
Figure Global Targeted Drugs for NSCLC Revenue Market Share by Types in 2018
Figure Target EGFR Picture
Figure Target ALK Picture
Figure Target HER2 Picture
Figure Target ROS1 Picture
Figure Target BRAF Picture
Figure Target MEK Picture
Figure Target VEGFR2 Picture
Figure Target VEGF Picture
Figure Target MET Picture
Table Global Targeted Drugs for NSCLC Revenue (Million USD) by Application (2014-2024)
Figure Targeted Drugs for NSCLC Revenue Market Share by Applications in 2018
Figure Squamous Cell Carcinoma of NSCLC Picture
Figure Adenocarcinoma of NSCLC Picture
Figure Large Cell Carcinoma of NSCLC Picture
Table Global Market Targeted Drugs for NSCLC Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (2014-2024)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Targeted Drugs for NSCLC Type and Applications
Table Allergan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Targeted Drugs for NSCLC Type and Applications
Table Amgen Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table ARIAD Pharmaceuticals (Takeda) Basic Information, Manufacturing Base and Competitors
Table ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Type and Applications
Table ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Beacon Pharma Limited Basic Information, Manufacturing Base and Competitors
Table Beacon Pharma Limited Targeted Drugs for NSCLC Type and Applications
Table Beacon Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table BeiGene Basic Information, Manufacturing Base and Competitors
Table BeiGene Targeted Drugs for NSCLC Type and Applications
Table BeiGene Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Targeted Drugs for NSCLC Type and Applications
Table Biocon Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer-Ingelheim Targeted Drugs for NSCLC Type and Applications
Table Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table Celgene Corporation Targeted Drugs for NSCLC Type and Applications
Table Celgene Corporation Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Drug International Limted Basic Information, Manufacturing Base and Competitors
Table Drug International Limted Targeted Drugs for NSCLC Type and Applications
Table Drug International Limted Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base and Competitors
Table Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Type and Applications
Table Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Genvio Pharma Limited Basic Information, Manufacturing Base and Competitors
Table Genvio Pharma Limited Targeted Drugs for NSCLC Type and Applications
Table Genvio Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table Hetero Drugs Targeted Drugs for NSCLC Type and Applications
Table Hetero Drugs Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table ImClone Systems (Eli Lilly) Basic Information, Manufacturing Base and Competitors
Table ImClone Systems (Eli Lilly) Targeted Drugs for NSCLC Type and Applications
Table ImClone Systems (Eli Lilly) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Incepta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Incepta Pharmaceuticals Targeted Drugs for NSCLC Type and Applications
Table Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Targeted Drugs for NSCLC Type and Applications
Table Mylan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Targeted Drugs for NSCLC Type and Applications
Table Novartis Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Targeted Drugs for NSCLC Type and Applications
Table Pfizer Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Reliance Lifesciences Basic Information, Manufacturing Base and Competitors
Table Reliance Lifesciences Targeted Drugs for NSCLC Type and Applications
Table Reliance Lifesciences Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Targeted Drugs for NSCLC Type and Applications
Table Roche Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Targeted Drugs for NSCLC Type and Applications
Table AstraZeneca Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Targeted Drugs for NSCLC Type and Applications
Table Cipla Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Targeted Drugs for NSCLC Type and Applications
Table Teva Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table OSI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table OSI Pharmaceuticals Targeted Drugs for NSCLC Type and Applications
Table OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Glenmark Pharmaceuticals Targeted Drugs for NSCLC Type and Applications
Table Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Natco Pharma Basic Information, Manufacturing Base and Competitors
Table Natco Pharma Targeted Drugs for NSCLC Type and Applications
Table Natco Pharma Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Global Targeted Drugs for NSCLC Revenue (Million USD) by Players (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue Share by Players (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Share by Players in 2017
Figure Global Targeted Drugs for NSCLC Revenue Share by Players in 2018
Figure Global Top 5 Players Targeted Drugs for NSCLC Revenue Market Share in 2018
Figure Global Top 10 Players Targeted Drugs for NSCLC Revenue Market Share in 2018
Figure Global Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue (Million USD) by Regions (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue Market Share by Regions (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Market Share by Regions (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Market Share by Regions in 2018
Figure North America Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Europe Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure South America Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Table North America Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
Table North America Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure North America Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure North America Targeted Drugs for NSCLC Revenue Market Share by Countries in 2018
Figure USA Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Canada Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Mexico Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Table Europe Targeted Drugs for NSCLC Revenue (Million USD) by Countries (2014-2019)
Figure Europe Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure Europe Targeted Drugs for NSCLC Revenue Market Share by Countries in 2018
Figure Germany Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure UK Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure France Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Russia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Italy Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Targeted Drugs for NSCLC Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Targeted Drugs for NSCLC Revenue Market Share by Countries in 2018
Figure China Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Japan Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Korea Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure India Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Table South America Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
Table South America Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure South America Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure South America Targeted Drugs for NSCLC Revenue Market Share by Countries in 2018
Figure Brazil Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Argentina Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Colombia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Targeted Drugs for NSCLC Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Targeted Drugs for NSCLC Revenue Market Share by Countries in 2018
Figure Saudi Arabia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure UAE Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Egypt Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Nigeria Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure South Africa Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue (Million USD) by Type (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue Share by Type (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Share by Type (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Share by Type in 2018
Table Global Targeted Drugs for NSCLC Revenue Forecast by Type (2019-2024)
Figure Global Targeted Drugs for NSCLC Market Share Forecast by Type (2019-2024)
Figure Global Target EGFR Revenue Growth Rate (2014-2019)
Figure Global Target ALK Revenue Growth Rate (2014-2019)
Figure Global Target HER2 Revenue Growth Rate (2014-2019)
Figure Global Target ROS1 Revenue Growth Rate (2014-2019)
Figure Global Target BRAF Revenue Growth Rate (2014-2019)
Figure Global Target MEK Revenue Growth Rate (2014-2019)
Figure Global Target VEGFR2 Revenue Growth Rate (2014-2019)
Figure Global Target VEGF Revenue Growth Rate (2014-2019)
Figure Global Target MET Revenue Growth Rate (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue by Application (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue Share by Application (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Share by Application (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Share by Application in 2018
Table Global Targeted Drugs for NSCLC Revenue Forecast by Application (2019-2024)
Figure Global Targeted Drugs for NSCLC Market Share Forecast by Application (2019-2024)
Figure Global Squamous Cell Carcinoma of NSCLC Revenue Growth Rate (2014-2019)
Figure Global Adenocarcinoma of NSCLC Revenue Growth Rate (2014-2019)
Figure Global Large Cell Carcinoma of NSCLC Revenue Growth Rate (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Targeted Drugs for NSCLC Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Targeted Drugs for NSCLC Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
Figure Europe Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
Figure South America Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
NSCLC用標的薬剤VEGFR2阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug VEGFR2 Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, espe…- NSCLC用標的薬物VEGF阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug VEGF Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especi…
- NSCLC用標的薬BRAF阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug BRAF Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especi…
- NSCLC用標的薬物HER2阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug HER2 Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especi…
- NSCLC用標的薬剤ROS1阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug ROS1 Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especi…